TrialBlood2015

A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia.

Susan M O'Brien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.